Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease

VIFORFRANCE1,100 enrolled

Overview

Despite its known prevalence in IBD, a recent study conducted with Prof. Cacoub (unpublished) on the national health insurance database showed that iron deficiency was an under-diagnosed and under-treated co-morbidity. In chronic diseases including IBD, Transferrin Saturation Factor is only performed in approximately 10% of cases, whereas it is recommended in inflammatory situations including IBD patients (HAS 2011). The objective of this study is therefore to obtain updated French data on the prevalence of iron deficiency in patients with IBD by applying the recommendations of ECCO and French Health High Authority (determination of ferritinemia and Transferrin Saturation Factor)

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

1,100

Conditions

Intestinal Disease

Interventions

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient, male or female, over 18 years old * Patient present at the hospital on the day of the study * Diagnosis of IBD on international criteria * Patient giving written consent Exclusion Criteria: * Protected patient: major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision; * pregnant, lactating or parturient woman; * Patient hospitalized without consent

Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease

Overview

Conditions

Interventions

Eligibility

Outcomes

Primary Outcomes